We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson’s Authorized Generic Lipitor Outpaces Sales of Ranbaxy’s Version
Watson’s Authorized Generic Lipitor Outpaces Sales of Ranbaxy’s Version
January 4, 2012
Generic versions of blockbuster cholesterol drug Lipitor raked in roughly 60 percent of sales during their first two weeks on the market, with Watson’s authorized generic beating Ranbaxy’s competitor.